Today: 30 November 2025
Subscribe
Browse Category

NYSE:JNJ News 18 October 2025 - 30 November 2025

Johnson & Johnson (JNJ) Stock Near Record Highs: What Investors Should Know Before the December 1, 2025 Market Open

Johnson & Johnson (JNJ) Stock Near Record Highs: What Investors Should Know Before the December 1, 2025 Market Open

Johnson & Johnson (NYSE: JNJ) heads into the new trading week sitting just under all‑time highs, after a powerful rally that’s pushed the healthcare giant toward a $500 billion market value. FinancialContent+1 With U.S. markets reopening on Monday, December 1,
30 November 2025
 ·  ·  ·  ·  · 
Johnson & Johnson’s $3.05 Billion Halda Therapeutics Deal Signals New Oncology Push After Stelara Patent Cliff

Johnson & Johnson’s $3.05 Billion Halda Therapeutics Deal Signals New Oncology Push After Stelara Patent Cliff

Johnson & Johnson has struck a $3.05 billion cash deal to acquire Halda Therapeutics, a privately held cancer-drug developer based in New Haven, Connecticut, in one of 2025’s biggest oncology takeovers so far. Reuters+1 The move deepens J&J’s bet on
17 November 2025
 ·  ·  ·  ·  ·  ·  ·  · 
Bristol Myers Squibb (BMY) Shares Slide as Milvexian Heart Trial Halted After Interim Review – What Investors Need to Know Today (14 November 2025)

Bristol Myers Squibb (BMY) Shares Slide as Milvexian Heart Trial Halted After Interim Review – What Investors Need to Know Today (14 November 2025)

Bristol Myers Squibb and Johnson & Johnson end a key Phase 3 heart study for milvexian, sending BMY stock lower even as the pharma giant leans on a strong growth portfolio and fresh financing firepower. Bristol-Myers Squibb Company (NYSE: BMY)
14 November 2025
 ·  ·  ·  ·  ·  · 
J&J Makes Bold Move: Orthopedics Spin-Off (“DePuy Synthes”) Announced – 2025 Forecast Raised

NJ Stock: What to Know Before the Bell on November 10, 2025 (Fresh FDA Wins, Dividend Date, and Legal Overhang)

Dateline: Monday, November 10, 2025 — pre‑market Johnson & Johnson (NYSE: JNJ) starts the new week with momentum from multiple drug approvals, a firm dividend timetable, and a still‑active litigation backdrop. Here’s a concise, investor‑focused briefing on the key developments
9 November 2025
 ·  ·  ·  ·  ·  ·  · 
Stocks Slip as Tech Wobble Returns; Layoffs Spike and Tariff Showdown Clouds Outlook — Stock Market Today (Nov. 6, 2025)

Top 5 US Stocks to Buy Today (Nov. 7, 2025): CEG, NEE, XOM, JNJ, KKR — Navigating Shutdown Flight Cuts, the AI Selloff, and Energy’s Repricing

Today’s US stock picks for Nov. 7, 2025, with fresh catalysts: nuclear power, energy, healthcare and private equity. Risks, reasons, and what to watch. Why today’s setup is unique The market is digesting a messy mix of macro and micro
7 November 2025
 ·  ·  ·  ·  ·  ·  ·  ·  · 
Kenvue (NYSE: KVUE) Stock Surges on $40B Buyout – Spin‑Off Saga, Tylenol Turmoil & Investor Outlook

Kenvue (NYSE: KVUE) Stock Surges on $40B Buyout – Spin‑Off Saga, Tylenol Turmoil & Investor Outlook

Company Overview & History Kenvue Inc. is a leading consumer health company formed from Johnson & Johnson’s storied consumer products division. The name “Kenvue” combines “ken” (knowledge) and “vue” (view), reflecting a vision of insight-driven care en.wikipedia.org. As a spin-off,
4 November 2025
 ·  ·  ·  ·  ·  ·  · 
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 18.10.2025

ENDEDLive coverage has endedEnded: October 20, 2025, 6:00 AM EDT Could $500 Monthly Invested Turn Into a $680K Dividend-Paying Portfolio With This Vanguard ETF? October 19, 2025, 5:56 AM EDT. One Vanguard ETF stands out for income investors: the Vanguard
18 October 2025
 ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  · 
1 2
Go toTop